Skip to main content

Articles

Page 4 of 26

  1. Alcohol consumption is common among young men and occurs in many contexts. The sexualized substance use literature has generated some insight into the role of alcohol alongside other substances in the context ...

    Authors: Trevor Goodyear, John L. Oliffe, Natasha Parent, Caroline Mniszak, Emily Jenkins and Rod Knight
    Citation: Harm Reduction Journal 2023 20:100
  2. People Who Use Drugs (PWUD) have lower vaccination uptake than the general population, and disproportionately experience the burden of harms from vaccine-preventable diseases. We conducted a national qualitati...

    Authors: Farihah Ali, Ashima Kaura, Cayley Russell, Matthew Bonn, Julie Bruneau, Nabarun Dasgupta, Sameer Imtiaz, Valérie Martel-Laferrière, Jürgen Rehm, Rita Shahin and Tara Elton-Marshall
    Citation: Harm Reduction Journal 2023 20:99
  3. Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of...

    Authors: Ilhame Anwar, Cécile Donadille, Camelia Protopopescu, David Michels, Joris Herin, Adélaïde Pladys, Danièle Bader, Patrizia Carrieri and Perrine Roux
    Citation: Harm Reduction Journal 2023 20:98

    The Correction to this article has been published in Harm Reduction Journal 2023 20:109

  4. Significant heterogeneity exists among people who use drugs (PWUD). We identify distinct profiles of syringe service program (SSP) clients to (a) evaluate differential risk factors across subgroups and (b) inf...

    Authors: Kyle J. Moon, Ian Bryant, Anne Trinh, Kathryn A. Hasenstab, Brittany Carter, Rick Barclay and Saira Nawaz
    Citation: Harm Reduction Journal 2023 20:97
  5. 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death...

    Authors: Théo Willeman, Nathan Grundig, Christine Pochon, David Michels, Nicolas Charpentier, Hélène Eysseric-Guérin, Nathalie Fouilhé Sam-Lai, Françoise Stanke-Labesque and Bruno Revol
    Citation: Harm Reduction Journal 2023 20:96
  6. Hepatitis C virus (HCV) treatment can effectively cure HCV among people who inject drugs (PWID). Perspectives of PWID treated in innovative models can reveal program features that address barriers to treatment...

    Authors: Shashi N. Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, Melinda Pai, Benjamin J. Eckhardt, Kristen M. Marks, Chunki Fong and Pedro Mateu-Gelabert
    Citation: Harm Reduction Journal 2023 20:95
  7. Scotland currently has the highest rates of drug-related deaths in Europe, so drug checking services are being explored due to their potential role in reducing these deaths and related harms. Drug checking ser...

    Authors: Hannah Carver, Danilo Falzon, Wendy Masterton, Bruce Wallace, Elizabeth V. Aston, Fiona Measham, Carole Hunter, Harry Sumnall, Rosalind Gittins, Fiona Raeburn, Vicki Craik, Saket Priyadarshi, Laura Rothney, Kira Weir and Tessa Parkes
    Citation: Harm Reduction Journal 2023 20:94
  8. Despite high rates of harm attributable to alcohol use itself and the associated marginalization of illicit drinkers in Vancouver’s Downtown Eastside (DTES), alcohol-specific harm reduction services there are ...

    Authors: Aaron Bailey, Brittany Graham, Myles Harps and George Sedore
    Citation: Harm Reduction Journal 2023 20:93
  9. Supported accommodation intends to address challenges arising following release from prison; however, impact of services, and of specific service components, is unclear. We describe key characteristics of supp...

    Authors: Daisy Gibbs, Emily Stockings, Sarah Larney, Daniel J. Bromberg, Anthony Shakeshaft and Sara Farnbach
    Citation: Harm Reduction Journal 2023 20:91
  10. Opioid use disorder (OUD) is overrepresented among people with criminal justice involvement; HIV is a common comorbidity in this population. This study aimed to examine how formerly incarcerated men living wit...

    Authors: Yangxi An, Christopher J. Hoffmann, Urvisha Bhoora, Pretty Ndini, Derrick Moyo, Laura Steiner, Sukholuhle Tshuma, Tonderai Mabuto, Jannie Hugo, Jill Owczarzak and Tessa S. Marcus
    Citation: Harm Reduction Journal 2023 20:90
  11. The Compassion, Inclusion and Engagement initiative (CIE) was a social contact intervention that operated in British Columbia between 2015 and 2021. The primary objective of CIE was to increase the participati...

    Authors: Sally Maguet, Nancy Laliberte, Laura Moore, Tammy Milkovich, Charlene Burmeister, Marnie Scow, Wendy Sproule, Naomi Dove and Sheila Martens
    Citation: Harm Reduction Journal 2023 20:89
  12. The opioid epidemic continues to be associated with high numbers of fatalities in the USA and other countries, driven mainly by the inclusion of potent synthetic opioids in street drugs. Drug checking by means...

    Authors: James A. Swartz, Marya Lieberman, A. David Jimenez, Mary Ellen Mackesy-Amiti, Heather D. Whitehead, Kathleen L. Hayes, Lisa Taylor and Elizabeth Prete
    Citation: Harm Reduction Journal 2023 20:87
  13. Community-based participatory research (CBPR) can directly involve non-academic community members in the research process. Existing resources for research ethics training can be inaccessible to team members wi...

    Authors: Jeffrey Morgan, Scott D. Neufeld, Heather Holroyd, Jean Ruiz, Tara Taylor, Seonaid Nolan and Stephanie Glegg
    Citation: Harm Reduction Journal 2023 20:86
  14. While e-cigarettes have been identified as an effective means of tobacco harm reduction, the degree to which these devices will realise their harm reduction potential will be determined in large part by how av...

    Authors: Neil McKeganey, Andrea Patton, Venus Marza and Gabriel Barnard
    Citation: Harm Reduction Journal 2023 20:85
  15. The economic, social, cultural and political milieus that influence injection drug-related HIV risk behaviors along the US–Mexico border in the previous decade have been studied comparing cities on an East–Wes...

    Authors: Julia Lechuga, Rebeca Ramos, Natasha Ludwig-Barron, Gilberto Perez, Maria Elena Ramos, João B. Ferreira-Pinto, Jacquelin I. Cordero, John Sauceda and Jorge Salazar
    Citation: Harm Reduction Journal 2023 20:84
  16. There were seven opioid overdoses in this New York City (NYC) federally qualified health center from December 2018 through February 2019, reflecting the rising rate of overdose deaths in NYC overall at the tim...

    Authors: Audrey Stephenson, Alessandra Calvo-Friedman, Lisa Altshuler, Sondra Zabar and Kathleen Hanley
    Citation: Harm Reduction Journal 2023 20:83

    The Correction to this article has been published in Harm Reduction Journal 2023 20:105

  17. Understanding drug use and behavior within the PWUD population is crucial to adapt harm reduction and prevention strategies, and provide improved addiction and medical treatment. However, in most countries suc...

    Authors: Hélène Donnadieu, Catherine Quillet, Morgana D’Ottavi, Joëlle Castellani, Anne Debellefontaine, Sylvain Guichard, René Baglioni, Nicolas Langendorfer, Vincent Faucherre, Bertrand Hanslik, Edouard Tuaillon, Didier Laureillard and Nicolas Nagot
    Citation: Harm Reduction Journal 2023 20:82
  18. Fentanyl has contributed to a sharp rise in the toxicity of the unregulated drug supply and fatal overdoses in Canada. It has also changed injection practices. Injection frequency has increased as a result and...

    Authors: Marilou Gagnon, Katherine Rudzinski, Adrian Guta, Rose A. Schmidt, David T. Kryszajtys, Gillian Kolla and Carol Strike
    Citation: Harm Reduction Journal 2023 20:81
  19. Solitary use of substances is a risk factor for substance use-related mortality. Novel e-health harm reduction interventions such as virtual overdose monitoring services (VOMS) have emerged in North America to...

    Authors: Tyler Marshall, Dylan Viste, Stephanie Jones, Julia Kim, Amanda Lee, Farah Jafri, Oona Krieg and S. Monty Ghosh
    Citation: Harm Reduction Journal 2023 20:80
  20. Research on women who inject drugs is scarce in low- and middle-income countries. Women experience unique harms such as sexism and sexual violence which translate into negative health outcomes. The present wor...

    Authors: Pablo Gonzalez-Nieto, Anabel Salimian, Jaime Arredondo, Lourdes Angulo, Alejandra García de Loera, Said Slim, Steve Shoptaw, Mary C. Cambou, Eileen V. Pitpitan and David Goodman-Meza
    Citation: Harm Reduction Journal 2023 20:79
  21. Despite the dramatic increase in opioid-related deaths in recent years, global access to treatment remains poor. A major barrier to people accessing Medication-assisted treatment of the opioid use disorder (MO...

    Authors: Sonam Prakashini Banka-Cullen, Catherine Comiskey, Peter Kelly, Mary Beth Zeni, Ana Gutierrez and Usha Menon
    Citation: Harm Reduction Journal 2023 20:78
  22. The World Health Organization has set a goal to reach world elimination of hepatitis C virus (HCV) by 2030. Needle and syringe programs (NSP) for people who inject drugs (PWID) are crucial to achieve this goal...

    Authors: E. Kågström, A. Lannergård, J. El Khosht, P. Lörelius, J. Månflod and S. Strömdahl
    Citation: Harm Reduction Journal 2023 20:77
  23. Globally, the rise in the number of people living with a substance use disorder (SUD) carries a multitude of individual and social health implications for carers and their families, often impacting negatively ...

    Authors: Ilze Swanepoel, Gretel Crafford, Stephan Geyer and Tessa S. Marcus
    Citation: Harm Reduction Journal 2023 20:76
  24. Fentanyl and fentanyl-related analogues are the main drivers of overdose death in the USA, particularly among people who inject drugs (PWID). Despite the fact that non-Hispanic whites exhibit higher population...

    Authors: R. Abadie
    Citation: Harm Reduction Journal 2023 20:75
  25. The COVID-19 pandemic particularly affected the health of vulnerable population, such as people who use drugs. Due to compromised baseline health status, certain drug uses and settings and socioeconomic depriv...

    Authors: Nacho Sánchez-Valdivia, Maria Gabriela Barbaglia, Marc Olivella-Cirici, Noelia Girona Marcos, Mercè Gotsens, Amaia Garrido Albaina, Cristina Rius, Montse Bartroli and Gloria Pérez
    Citation: Harm Reduction Journal 2023 20:74
  26. People who inject drugs (PWID) represent a population with an increased prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach the WHO goal of eliminating HCV as a major pub...

    Authors: K. Lindqvist, Z. Thorin and M. Kåberg
    Citation: Harm Reduction Journal 2023 20:72
  27. The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID...

    Authors: Lyra Cooper, Joseph G. Rosen, Leanne Zhang, Danielle Pelaez, Praise F. Olatunde, Jill Owczarzak, Ju Nyeong Park and Jennifer L. Glick
    Citation: Harm Reduction Journal 2023 20:71
  28. Unprecedented increases in substance-related overdose fatalities have been observed in Texas and the U.S. since the onset of the COVID-19 pandemic and have made clear there is considerable need to reduce harms...

    Authors: Kasey Claborn, Jake Samora, Katie McCormick, Quanisha Whittfield, Frederic Courtois, Kyle Lozada, Daniel Sledge, Annie Burwell, Sandra Chavez, Jamie Bailey, Chris Bailey, Chelsea Dalton Pederson, Claire Zagorski, Lucas Hill, Fiona N. Conway, Lori Holleran Steiker…
    Citation: Harm Reduction Journal 2023 20:70
  29. The opioid overdose crisis in the USA has called for expanding access to evidence-based substance use treatment programs, yet many barriers limit the ability of people who inject drugs (PWID) to engage in thes...

    Authors: Abigail K. Winiker, Kristin E. Schneider, Rebecca Hamilton White, Allison O’Rourke, Suzanne M. Grieb and Sean T. Allen
    Citation: Harm Reduction Journal 2023 20:69
  30. Brass screens are considered an essential part of the safer drug smoking/inhalation supplies and are widely distributed by harm reduction programs in Canada. However, the use of commercially available steel wo...

    Authors: Bradley J. Diak, Miroslav Miskovic, Nadia Zurba and Denise Beaumont
    Citation: Harm Reduction Journal 2023 20:68
  31. Authors: Muhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, Ranimah Yahya, Wan Ruzilasalwa Wan Sulaiman, Siti Aminah Akbar Merican, Darisah Lah, Xiaohui Sem and Sonjelle Shilton
    Citation: Harm Reduction Journal 2023 20:67

    The original article was published in Harm Reduction Journal 2023 20:48

  32. Heroin-Assisted Treatment (HAT) is well evidenced internationally to improve health and social outcomes for people dependent on opioids who have not been helped by traditional treatment options. Despite this e...

    Authors: Fleur Riley, Magdalena Harris, Hannah Louise Poulter, Helen J. Moore, Daniel Ahmed, Graham Towl and Tammi Walker
    Citation: Harm Reduction Journal 2023 20:66
  33. Electronic nicotine delivery systems (ENDS), such as the JUUL system, are nicotine products for adults who currently smoke cigarettes but are looking for an alternative to combustible cigarettes. Sales of ENDS...

    Authors: Yingying Xu, Anindya Sen, Tengjiao Chen, Christopher M. Harris and Shivaani Prakash
    Citation: Harm Reduction Journal 2023 20:65
  34. In response to the ongoing opioid epidemic, there have been efforts to develop novel harm reduction strategies alongside scaling of currently implemented programs. Virtual overdose monitoring services (VOMS) a...

    Authors: Fahad Safi, William Rioux, Nathan Rider, Barbara Fornssler, Stephanie Jones and S. Monty Ghosh
    Citation: Harm Reduction Journal 2023 20:64
  35. To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020–2022) in New York City (NYC).

    Authors: Don C. Des Jarlais, Chenziheng Allen Weng, Jonathan Feelemyer and Courtney McKnight
    Citation: Harm Reduction Journal 2023 20:63
  36. Past research has either focused on alcohol or drug preloading before a night out, but not on the interaction between them. With increased risks of harm through interaction effects, we wished to build upon pre...

    Authors: Lee R. J. Hughes, Corey Allen and Grant J. Devilly
    Citation: Harm Reduction Journal 2023 20:62
  37. The adulteration of the illicit drug supply with fentanyl and its analogues is driving the ongoing overdose crisis in North America. While various harm reduction interventions address overdose-related risks, t...

    Authors: Manal Mansoor, Annie Foreman-Mackey, Andrew Ivsins and Geoff Bardwell
    Citation: Harm Reduction Journal 2023 20:61
  38. Preliminary evidence suggests that people who inject drugs (PWID) may be at an increased risk of developing infective endocarditis (IE), hepatitis C virus (HCV) infection, and/or human immunodeficiency virus (...

    Authors: Andrea C. Tricco, Amanda Parker, Areej Hezam, Vera Nincic, Fatemeh Yazdi, Yonda Lai, Charmalee Harris, Zachary Bouck, Ahmed M. Bayoumi and Sharon E. Straus
    Citation: Harm Reduction Journal 2023 20:60
  39. The injection of morphine from morphine sulfate capsules containing sustained-release microbeads (Skenan®) is a practice frequently described by French intravenous opioid users. They seek an injectable form of...

    Authors: Célian Bertin, Edouard Montigne, Sarah Teixeira, Florent Ferrer, Louis Lauwerie, Damien Richard and Nicolas Authier
    Citation: Harm Reduction Journal 2023 20:59
  40. In the US, stimulant use is associated with a 3–6 times greater rate of HIV seroconversion in sexual minority men (SMM) than in those who do not use stimulants. Annually, 1 in 3 SMM who HIV seroconvert will be...

    Authors: Leah Davis-Ewart, Ji-Young Lee, Michael Viamonte, Josè Colon-Burgos, Audrey Harkness, Mariano Kanamori, Dustin T. Duncan, Susanne Doblecki-Lewis, Adam W. Carrico and Christian Grov
    Citation: Harm Reduction Journal 2023 20:58
  41. Authors: Isabelle Volpe, Rita Brien, Jasmin Grigg, Stephanie Tzanetis, Sione Crawford, Tom Lyons, Nicole Lee, Ginny McKinnon, Caitlin Hughes, Alan Eade and Monica J. Barratt
    Citation: Harm Reduction Journal 2023 20:55

    The original article was published in Harm Reduction Journal 2023 20:3

  42. There are growing concerns about illicitly manufactured fentanyl (IMF) contamination of methamphetamine. This study aims to characterize the lay views and experiences with IMF-contaminated methamphetamine (IMF...

    Authors: Raminta Daniulaityte, Lance Ruhter, Matthew Juhascik and Sydney Silverstein
    Citation: Harm Reduction Journal 2023 20:54
  43. As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs to replace...

    Authors: Marlene Haines and Patrick O’Byrne
    Citation: Harm Reduction Journal 2023 20:53
  44. The intention of chemsex-practicing gay and bisexual men and other men who have sex with men (GBMSM) to reduce their drug use is an important factor for the utilization of harm reduction services. This study a...

    Authors: Yu-Ru Hung, Tsan-Tse Chuang, Tsai-Wei Chen, An-Chun Chung, Meng-Tzu Wu, Su-Ting Hsu, Nai-Ying Ko and Carol Strong
    Citation: Harm Reduction Journal 2023 20:52
  45. Since the onset of the COVID-19 pandemic, overdose rates in North America have continued to rise, with more than 100,000 drug poisoning deaths in the past year. Amidst an increasingly toxic drug supply, the pa...

    Authors: Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook, Scott MacDonald, Scott Harrison, Julie Lajeunesse, David Byres, Martin Schechter and Eugenia Oviedo-Joekes
    Citation: Harm Reduction Journal 2023 20:51